A Tribute to Dr. Paul A. J. Janssen: Entrepreneur Extraordinaire, Innovative Scientist, and Significant Contributor to Anesthesiology

Abstract

In Brief Dr. Paul Janssen was the founder of Janssen Pharmaceutica and the developer of over 80 pharmaceutical compounds that proved useful in human, botanical, and veterinary medicine. He and his coworkers synthesized the fentanyl family of drugs, many other potent analgesics, droperidol, etomidate, and numerous other important medicines that were extremely useful in psychiatry, parasitology, gastroenterology, cardiology, virology, and immunology. Anesthesiology and medicine as a whole have benefited a great deal from his resourcefulness, creativity, and entrepreneurial spirit. IMPLICATIONS: Few in the field of anesthesiology appreciate the sheer magnitude of Dr. Janssen’s numerous contributions to various fields in human, botanical, and veterinary medicine. From the invention and development of over 80 pharmaceutical compounds to his monumental merger of Janssen Pharmacuetica with Johnson and Johnson, Dr. Paul Janssen truly embodies what it means to be a productive scientist and an entrepreneur extraordinaire.

Cite this work

No public copy is stored for this record, so only the metadata is cited.

Stored only when both papers are in the corpus — 76 citations exist upstream.